# Tavio Capital LLC

> Institutional holdings reported to the SEC as of Q2 2020 on Form 13F. CIK 1672526. Source: https://holderbook.com/funds/1672526-tavio-capital-llc/

- Reported value: $75.4M
- Positions: 8
- Weight of the ten largest: 100.0%
- Filed: 2020-08-13

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| MOLINA HEALTHCARE INC | [MOH](https://holderbook.com/stocks/MOH/) | $16.3M | 91,479 | 21.6% | 7 |
| MCKESSON CORP | [MCK](https://holderbook.com/stocks/MCK/) | $15.3M | 99,594 | 20.3% | 5 |
| ZIMMER BIOMET HOLDINGS INC | [ZBH](https://holderbook.com/stocks/ZBH/) | $15.3M | 127,819 | 20.2% | 7 |
| THE CIGNA GROUP | [CI](https://holderbook.com/stocks/CI/) | $14.1M | 75,163 | 18.7% | 4 |
| BAXTER INTL INC | [BAX](https://holderbook.com/stocks/BAX/) | $5.9M | 68,405 | 7.8% | 1 |
| PATTERSON COS INC | [PDCO](https://holderbook.com/stocks/PDCO/) | $4.5M | 202,943 | 5.9% | 1 |
| EXACT SCIENCES CORP | [EXAS](https://holderbook.com/stocks/EXAS/) | $3.0M | 34,329 | 4.0% | 1 |
| CENTENE CORP DEL | [CNC](https://holderbook.com/stocks/CNC/) | $1.2M | 18,615 | 1.6% | 3 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2020 | +15.5% | +19.6% | -4.1% | 100% |
| Q1 2020 | -18.4% | -19.9% | +1.5% | 100% |
| Q4 2019 | +15.1% | +8.5% | +6.6% | 100% |
| Q3 2019 | -6.5% | +1.3% | -7.8% | 100% |
| Q2 2019 | +0.3% | +3.7% | -3.5% | 100% |
| Q1 2019 | +12.9% | +13.0% | -0.2% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2020 | $75.4M | 8 |
| Q1 2020 | $69.3M | 6 |
| Q4 2019 | $271.3M | 12 |
| Q3 2019 | $189.2M | 11 |
| Q2 2019 | $246.4M | 10 |
| Q1 2019 | $271.3M | 13 |
| Q4 2018 | $240.8M | 15 |